BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Kaipainen P, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012;7:e33723. [PMID: 22470463 DOI: 10.1371/journal.pone.0033723] [Cited by in Crossref: 295] [Cited by in F6Publishing: 232] [Article Influence: 29.5] [Reference Citation Analysis]
Number Citing Articles
1 Takenoshita S, Sakai N, Chiba Y, Matsumura M, Yamaguchi M, Nishino S. An overview of hypocretin based therapy in narcolepsy. Expert Opinion on Investigational Drugs 2018;27:389-406. [DOI: 10.1080/13543784.2018.1459561] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
2 Dye TJ, Gurbani N, Simakajornboon N. Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev 2018;25:14-8. [PMID: 28108192 DOI: 10.1016/j.prrv.2016.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
3 Juvodden HT, Alnæs D, Lund MJ, Agartz I, Andreassen OA, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives. Sleep 2018;41. [DOI: 10.1093/sleep/zsy145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 O'Hagan DT, Ott GS, Nest GV, Rappuoli R, Giudice GD. The history of MF59(®) adjuvant: a phoenix that arose from the ashes. Expert Rev Vaccines 2013;12:13-30. [PMID: 23256736 DOI: 10.1586/erv.12.140] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 18.0] [Reference Citation Analysis]
5 De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA, Ross TM, Martin W. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Hum Vaccin Immunother 2014;10:256-62. [PMID: 24525618 DOI: 10.4161/hv.28135] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
6 Partinen M, Kronholm E. Epidemiology: Principles and Application in Sleep Medicine. In: Chokroverty S, editor. Sleep Disorders Medicine. New York: Springer; 2017. pp. 485-521. [DOI: 10.1007/978-1-4939-6578-6_28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Dauvilliers Y, Jaussent I, Lecendreux M, Scholz S, Bayard S, Cristol JP, Blain H, Dupuy AM. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav Immun 2014;37:260-6. [PMID: 24394344 DOI: 10.1016/j.bbi.2013.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
8 Petrovsky N. Vaccine adjuvant safety: the elephant in the room. Expert Rev Vaccines 2013;12:715-7. [PMID: 23885815 DOI: 10.1586/14760584.2013.811198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
9 Cauchi M, Ball H, Ben-Shlomo Y, Robertson N. Interpretation of vaccine associated neurological adverse events: a methodological and historical review. J Neurol 2021. [PMID: 34398270 DOI: 10.1007/s00415-021-10747-8] [Reference Citation Analysis]
10 Mosakhani N, Sarhadi V, Panula P, Partinen M, Knuutila S. Narcolepsy patients' blood-based miRNA expression profiling: miRNA expression differences with Pandemrix vaccination. Acta Neurol Scand 2017;136:462-9. [PMID: 28251619 DOI: 10.1111/ane.12749] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kim WJ, Lee SD, Lee E, Namkoong K, Choe KW, Song JY, Cheong HJ, Jeong HW, Heo JY. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers. Vaccine 2015;33:4868-72. [PMID: 26238720 DOI: 10.1016/j.vaccine.2015.07.055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
12 Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res 2014;23:414-9. [PMID: 24645699 DOI: 10.1111/jsr.12143] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
13 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
14 Jacob L, Dauvilliers Y. La narcolepsie avec cataplexie : une maladie auto-immune ? Med Sci (Paris) 2014;30:1136-43. [DOI: 10.1051/medsci/20143012017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Filardi M, Pizza F, Bruni O, Natale V, Plazzi G. Circadian Rest-Activity Rhythm in Pediatric Type 1 Narcolepsy. Sleep 2016;39:1241-7. [PMID: 27091539 DOI: 10.5665/sleep.5842] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
16 Ahout I, Ferwerda G, de Groot R. Influenza vaccination in kids, are you kidding me? Journal of Infection 2014;68:S100-7. [DOI: 10.1016/j.jinf.2013.09.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sturkenboom MC. The narcolepsy-pandemic influenza story: Can the truth ever be unraveled? Vaccine 2015;33:B6-B13. [DOI: 10.1016/j.vaccine.2015.03.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
18 Zhang Z, Dauvilliers Y, Plazzi G, Mayer G, Lammers GJ, Santamaria J, Partinen M, Overeem S, Del Rio Villegas R, Sonka K, Peraita-Adrados R, Heinzer R, Wierzbicka A, Högl B, Manconi M, Feketeova E, da Silva AM, Bušková J, Bassetti CLA, Barateau L, Pizza F, Antelmi E, Gool JK, Fronczek R, Gaig C, Khatami R. Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis. Nat Sci Sleep 2022;14:1031-47. [PMID: 35669411 DOI: 10.2147/NSS.S359980] [Reference Citation Analysis]
19 Schinkelshoek MS, Fronczek R, Kooy-Winkelaar EMC, Petersen J, Reid HH, van der Heide A, Drijfhout JW, Rossjohn J, Lammers GJ, Koning F. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. J Neuroimmunol 2019;332:167-75. [PMID: 31048269 DOI: 10.1016/j.jneuroim.2019.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
20 Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015;47:44-57. [PMID: 25452148 DOI: 10.1016/j.bbi.2014.11.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
21 Kępińska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry 2020;11:72. [PMID: 32174851 DOI: 10.3389/fpsyt.2020.00072] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
22 Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J. Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation. Vaccine 2013;31:994-1007. [DOI: 10.1016/j.vaccine.2012.12.014] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
23 Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Curr Opin Pulm Med 2014;20:242-6. [PMID: 24637227 DOI: 10.1097/MCP.0000000000000049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
24 Imanishi A, Kanbayashi T, Sagawa Y, Taniguchi T, Usumoto A, Yuge K, Kotorii N, Kinoshita T, Hirai T, Omori Y, Yoshizawa K, Shimizu T. Normal CSF orexin levels in the patients with hypersomnolence following HPV vaccination. Sleep Biol Rhythms 2019;17:259-61. [DOI: 10.1007/s41105-019-00210-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Nordstrand SEH, Juvodden HT, Viste R, Rootwelt T, Karlsen T, Thorsby PM, Swanson D, Nilsen KB, Hansen BH, Knudsen-heier S. Obesity and other medical comorbidities among NT1 patients after the Norwegian H1N1 influenza epidemic and vaccination campaign. Sleep 2020;43:zsz277. [DOI: 10.1093/sleep/zsz277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Jalilian B, Christiansen SH, Einarsson HB, Pirozyan MR, Petersen E, Vorup-Jensen T. Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities? Mol Cell Ther 2013;1:2. [PMID: 26056568 DOI: 10.1186/2052-8426-1-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
27 Esposito S, Prada E, Mastrolia MV, Tarantino G, Codecà C, Rigante D. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background. Immunol Res 2014;60:366-75. [PMID: 25395340 DOI: 10.1007/s12026-014-8586-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
28 Neuzil KM, Tsvetnitsky V, Nyari LJ, Bright RA, Boslego JW; PATH's Influenza Vaccine Project team. PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries. Expert Rev Vaccines 2012;11:939-47. [PMID: 23002975 DOI: 10.1586/erv.12.76] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Miyagawa T, Tanaka S, Shimada M, Sakai N, Tanida K, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kanbayashi T, Imanishi A, Ikegami A, Kamei Y, Hida A, Wada Y, Miyamoto M, Takami M, Kondo H, Tamura Y, Taniyama Y, Omata N, Mizuno T, Moriya S, Furuya H, Kato M, Kato K, Ishigooka J, Tsuruta K, Chiba S, Yamada N, Okawa M, Hirata K, Kuroda K, Kume K, Uchimura N, Kitada M, Kodama T, Inoue Y, Nishino S, Mishima K, Tokunaga K, Honda M. A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia. NPJ Genom Med 2022;7:29. [PMID: 35414074 DOI: 10.1038/s41525-022-00298-w] [Reference Citation Analysis]
30 Ollila HM, Ravel JM, Han F, Faraco J, Lin L, Zheng X, Plazzi G, Dauvilliers Y, Pizza F, Hong SC, Jennum P, Knudsen S, Kornum BR, Dong XS, Yan H, Hong H, Coquillard C, Mahlios J, Jolanki O, Einen M, Arnulf I, Högl B, Frauscher B, Crowe C, Partinen M, Huang YS, Bourgin P, Vaarala O, Désautels A, Montplaisir J, Mack SJ, Mindrinos M, Fernandez-Vina M, Mignot E. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 2015;96:136-46. [PMID: 25574827 DOI: 10.1016/j.ajhg.2014.12.010] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 14.0] [Reference Citation Analysis]
31 Han F, Lin L, Li J, Dong XS, Mignot E. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 2013;73:560. [PMID: 23225098 DOI: 10.1002/ana.23799] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
32 Russell RF, McDonald JU, Lambert L, Tregoning JS. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice. J Virol 2016;90:4735-44. [PMID: 26912628 DOI: 10.1128/JVI.03159-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
33 Edwards K, Lambert PH, Black S. Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic. Pediatr Infect Dis J 2019;38:873-6. [PMID: 31306400 DOI: 10.1097/INF.0000000000002398] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
34 Fugger L, Steinman L. A scientific sequel to Stieg Larsson: relationship between Pandemrix--pandemic influenza vaccine--and the subsequent development of narcolepsy. J Intern Med 2014;275:195-7. [PMID: 24286291 DOI: 10.1111/joim.12158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
36 Chen YH, Huang YS, Chien WH, Chen CH. Association analysis of the major histocompatibility complex, class II, DQ β1 gene, HLA-DQB1, with narcolepsy in Han Chinese patients from Taiwan. Sleep Med 2013;14:1393-7. [PMID: 24157097 DOI: 10.1016/j.sleep.2013.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
37 Vashishtha VM, Kalra A, Choudhury P. Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013. Indian Pediatr 2013;50:867-74. [PMID: 24096845 DOI: 10.1007/s13312-013-0230-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
38 Butler M, Tamborska A, Wood GK, Ellul M, Thomas RH, Galea I, Pett S, Singh B, Solomon T, Pollak TA, Michael BD, Nicholson TR. Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder. J Neurol Neurosurg Psychiatry 2021:jnnp-2021-326924. [PMID: 34362855 DOI: 10.1136/jnnp-2021-326924] [Reference Citation Analysis]
39 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
40 Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A; Narcoflu-VF study group. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013;136:2486-96. [PMID: 23884811 DOI: 10.1093/brain/awt187] [Cited by in Crossref: 163] [Cited by in F6Publishing: 126] [Article Influence: 18.1] [Reference Citation Analysis]
41 Stowe J, Andrews N, Gringras P, Quinnell T, Zaiwalla Z, Shneerson J, Miller E. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study. PLoS Med 2020;17:e1003225. [PMID: 32926731 DOI: 10.1371/journal.pmed.1003225] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
43 Melén K, Jalkanen P, Kukkonen JP, Partinen M, Nohynek H, Vuorela A, Vaarala O, Freitag TL, Meri S, Julkunen I. No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children. J Transl Autoimmun 2020;3:100055. [PMID: 32743535 DOI: 10.1016/j.jtauto.2020.100055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Fernell E, Sundin M, Fasth A, Dinkler L, Galazka M, Gillberg C, Johnson M. Paediatric Acute onset Neuropsychiatric Syndrome: Exploratory study finds no evidence of HLA class II association but high rate of autoimmunity in first-degree relatives. Acta Paediatr 2022;111:820-4. [PMID: 33566388 DOI: 10.1111/apa.15805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O'Malley S, Lynch B, Crowe C. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. [PMID: 33289477 DOI: 10.5664/jcsm.9052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Thebault S, Waters P, Snape MD, Cottrell D, Darin N, Hallböök T, Huutoniemi A, Partinen M, Pollard AJ, Vincent A. Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination. PLoS One 2015;10:e0129555. [PMID: 26090827 DOI: 10.1371/journal.pone.0129555] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
47 Lamb F, Ploner A, Fink K, Maeurer M, Bergman P, Piehl F, Weibel D, Sparén P, Dahlström LA. No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination. PLoS One 2016;11:e0154296. [PMID: 27120092 DOI: 10.1371/journal.pone.0154296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013;23:767-73. [PMID: 23725858 DOI: 10.1016/j.conb.2013.04.013] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 12.2] [Reference Citation Analysis]
49 Khazeni N, Hutton DW, Collins CI, Garber AM, Owens DK. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Ann Intern Med 2014;160:684-94. [PMID: 24842415 DOI: 10.7326/M13-2071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Hall GC, Hill F. Descriptive investigation of the recording of influenza vaccination details on The Health Information Network database: VALIDATION OF DATABASE VACCINE RECORDING. Pharmacoepidemiol Drug Saf 2014;23:595-600. [DOI: 10.1002/pds.3515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Mayer G, Bassetti CL, Dauvilliers Y. Treatment options in narcolepsy. Expert Opinion on Orphan Drugs 2013;1:987-99. [DOI: 10.1517/21678707.2013.854701] [Reference Citation Analysis]
52 Bårdsen K, Gjerstad MD, Partinen M, Kvivik I, Tjensvoll AB, Ruoff P, Omdal R, Brede C. Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay. Anal Chem 2019;91:9323-9. [DOI: 10.1021/acs.analchem.9b02710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Posar A, Pizza F, Parmeggiani A, Plazzi G. Neuropsychological findings in childhood narcolepsy. J Child Neurol 2014;29:1370-6. [PMID: 24293310 DOI: 10.1177/0883073813508315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
54 Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y. Adjuvanted influenza vaccines. Expert Rev Vaccines 2013;12:1095-108. [PMID: 24053401 DOI: 10.1586/14760584.2013.825445] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
55 Szakács A, Hallböök T, Tideman P, Darin N, Wentz E. Psychiatric comorbidity and cognitive profile in children with narcolepsy with or without association to the H1N1 influenza vaccination. Sleep 2015;38:615-21. [PMID: 25325473 DOI: 10.5665/sleep.4582] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
56 Baker MA, Nguyen M, Cole DV, Lee GM, Lieu TA. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization. Vaccine 2013;31 Suppl 10:K98-112. [PMID: 24331080 DOI: 10.1016/j.vaccine.2013.04.088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
57 Verstraeten T, Cohet C, Dos Santos G, Ferreira GL, Bollaerts K, Bauchau V, Shinde V. Pandemrix™ and narcolepsy: A critical appraisal of the observational studies. Hum Vaccin Immunother 2016;12:187-93. [PMID: 26379011 DOI: 10.1080/21645515.2015.1068486] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
58 Oberle D, Drechsel-Bäuerle U, Schmidtmann I, Mayer G, Keller-Stanislawski B. Incidence of Narcolepsy in Germany. Sleep 2015;38:1619-28. [PMID: 25902804 DOI: 10.5665/sleep.5060] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
59 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
60 ter Meulen J, Casimiro D, Coller B, Heinrichs J, Bhambhani A. Winning a Race Against Evolving Pathogens with Novel Platforms and Universal Vaccines. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Elsevier; 2015. pp. 251-87. [DOI: 10.1016/b978-0-12-416603-5.00011-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, Tamhane T, Burgdorf KS, Ullum H, Jennum P, Knudsen S, Hadrup SR, Kornum BR. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun 2019;10:837. [PMID: 30783092 DOI: 10.1038/s41467-019-08774-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 14.3] [Reference Citation Analysis]
62 Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G. The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews 2018;38:70-85. [DOI: 10.1016/j.smrv.2017.04.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
63 Black SW, Kilduff TS. H1N1 infection of sleep/wake regions results in narcolepsy-like symptoms. Proc Natl Acad Sci USA 2016;113:476-7. [DOI: 10.1073/pnas.1524150113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Zhang X, Penzel T, Han F. Increased incidence of narcolepsy following the 2009 H1N1 pandemic. Somnologie 2013;17:90-3. [DOI: 10.1007/s11818-013-0619-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
65 Dye TJ, Jain SV, Kothare SV. Central Hypersomnia. Semin Pediatr Neurol 2015;22:93-104. [PMID: 26072339 DOI: 10.1016/j.spen.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
66 Veizades S, Tso A, Nguyen PK. Infection, inflammation and thrombosis: a review of potential mechanisms mediating arterial thrombosis associated with influenza and severe acute respiratory syndrome coronavirus 2. Biol Chem 2021. [PMID: 34957734 DOI: 10.1515/hsz-2021-0348] [Reference Citation Analysis]
67 Duffy J, Weintraub E, Vellozzi C, DeStefano F; Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014;83:1823-30. [PMID: 25320099 DOI: 10.1212/WNL.0000000000000987] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 6.4] [Reference Citation Analysis]
68 Wilkins AL, Kazmin D, Napolitani G, Clutterbuck EA, Pulendran B, Siegrist CA, Pollard AJ. AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Front Immunol 2017;8:1760. [PMID: 29326687 DOI: 10.3389/fimmu.2017.01760] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
69 Zhang J, Han F. Sleepiness in Narcolepsy. Sleep Medicine Clinics 2017;12:323-30. [DOI: 10.1016/j.jsmc.2017.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Brinth LS, Pors K, Theibel AC, Mehlsen J. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015;33:2602-2605. [PMID: 25882168 DOI: 10.1016/j.vaccine.2015.03.098] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 9.3] [Reference Citation Analysis]
71 Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Immunotherapy in Narcolepsy. Curr Treat Options Neurol 2020;22:2. [PMID: 31997035 DOI: 10.1007/s11940-020-0609-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev 2018;38:177-86. [PMID: 28847694 DOI: 10.1016/j.smrv.2017.06.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 16.6] [Reference Citation Analysis]
73 Wasling HB, Bornstein A, Wasling P. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study. Sleep Med 2020;76:104-12. [PMID: 33152582 DOI: 10.1016/j.sleep.2020.10.014] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Melzi S, Morel AL, Scoté-Blachon C, Liblau R, Dauvilliers Y, Peyron C. Histamine in murine narcolepsy: What do genetic and immune models tell us? Brain Pathol 2021;:e13027. [PMID: 34672414 DOI: 10.1111/bpa.13027] [Reference Citation Analysis]
75 Kornum BR, Pizza F, Knudsen S, Plazzi G, Jennum P, Mignot E. Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset. Brain Behav Immun 2015;49:54-8. [PMID: 25771509 DOI: 10.1016/j.bbi.2015.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
76 Szakács A, Chaplin JE, Tideman P, Strömberg U, Nilsson J, Darin N, Hallböök T. A population-based and case-controlled study of children and adolescents with narcolepsy: Health-related quality of life, adaptive behavior and parental stress. European Journal of Paediatric Neurology 2019;23:288-95. [DOI: 10.1016/j.ejpn.2019.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
77 Pérez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10:S112-23. [PMID: 29445535 DOI: 10.21037/jtd.2017.10.161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
78 Jiang W, Birtley JR, Hung SC, Wang W, Chiou SH, Macaubas C, Kornum B, Tian L, Huang H, Adler L, Weaver G, Lu L, Ilstad-Minnihan A, Somasundaram S, Ayyangar S, Davis MM, Stern LJ, Mellins ED. In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. Nat Commun 2019;10:5247. [PMID: 31748512 DOI: 10.1038/s41467-019-13234-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
79 Barker CI, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis 2014;14:227-38. [PMID: 24360892 DOI: 10.1016/S1473-3099(13)70238-X] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 6.9] [Reference Citation Analysis]
80 Maski K, Owens J. Pediatric Sleep Disorders. Continuum (Minneap Minn) 2018;24:210-27. [PMID: 29432244 DOI: 10.1212/CON.0000000000000566] [Reference Citation Analysis]
81 He D, Zhang H, Xiao J, Zhang X, Xie M, Pan D, Wang M, Luo X, Bu B, Zhang M, Wang W. Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis. Ann Neurol 2018;84:386-400. [PMID: 30246904 DOI: 10.1002/ana.25267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
82 Huppertz HI; Kommission für Infektionskrankheiten und Impffragen der Deutschen Akademie für Kinder- und Jugendmedizin e. V. (DAKJ). [Recommendations on the approach when unusual neurological symptoms occur in temporal association with vaccinations in childhood and adolescence]. Monatsschr Kinderheilkd 2020;:1-7. [PMID: 32836398 DOI: 10.1007/s00112-020-00975-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Harris T, Wong K, Stanford L, Fediurek J, Crowcroft N, Deeks S. Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data. Euro Surveill 2014;19:20900. [PMID: 25232921 DOI: 10.2807/1560-7917.es2014.19.36.20900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
84 Choe YJ, Bae G, Lee D. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: An ecological study. Vaccine 2012;30:7439-42. [DOI: 10.1016/j.vaccine.2012.10.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
85 Tanaka S, Honda M, Toyoda H, Kodama T. Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy. Human Immunology 2014;75:940-4. [DOI: 10.1016/j.humimm.2014.06.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
86 Saariaho AH, Vuorela A, Freitag TL, Pizza F, Plazzi G, Partinen M, Vaarala O, Meri S. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J Autoimmun 2015;63:68-75. [PMID: 26227560 DOI: 10.1016/j.jaut.2015.07.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
87 Ljung R, Sundström A, Grünewald M, Backman C, Feltelius N, Gedeborg R, Zethelius B. The profile of the COvid-19 VACcination register SAFEty study in Sweden (CoVacSafe-SE). Ups J Med Sci 2021;126. [PMID: 34984096 DOI: 10.48101/ujms.v126.8136] [Reference Citation Analysis]
88 Barclay T, Petrovsky N. Vaccine Adjuvant Nanotechnologies. Micro and Nanotechnology in Vaccine Development. Elsevier; 2017. pp. 127-47. [DOI: 10.1016/b978-0-323-39981-4.00007-5] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 Zrzavy T, Kollaritsch H, Rommer PS, Boxberger N, Loebermann M, Wimmer I, Winkelmann A, Zettl UK. Vaccination in Multiple Sclerosis: Friend or Foe? Front Immunol 2019;10:1883. [PMID: 31440255 DOI: 10.3389/fimmu.2019.01883] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
90 Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014;56:1117-23. [PMID: 25041214 DOI: 10.1111/dmcn.12522] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
91 Song JH, Kim TW, Um YH, Hong SC. Narcolepsy: Association with H1N1 Infection and Vaccination. Sleep Med Res 2016;7:43-7. [DOI: 10.17241/smr.2016.00101] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Svensson M, Ramelius A, Nilsson AL, Delli AJ, Elding Larsson H, Carlsson A, Forsander G, Ivarsson SA, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Örtqvist E, Lernmark Å; Better Diabetes Diagnosis (BDD) study group. Antibodies to influenza virus A/H1N1 hemagglutinin in Type 1 diabetes children diagnosed before, during and after the SWEDISH A(H1N1)pdm09 vaccination campaign 2009-2010. Scand J Immunol 2014;79:137-48. [PMID: 24313339 DOI: 10.1111/sji.12138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
94 Kornum BR, Burgdorf KS, Holm A, Ullum H, Jennum P, Knudsen S. Absence of autoreactive CD4 + T-cells targeting HLA-DQA1*01:02/DQB1*06:02 restricted hypocretin/orexin epitopes in narcolepsy type 1 when detected by EliSpot. Journal of Neuroimmunology 2017;309:7-11. [DOI: 10.1016/j.jneuroim.2017.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
95 Honda-Okubo Y, Kolpe A, Li L, Petrovsky N. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection. Vaccine 2014;32:4651-9. [PMID: 24958701 DOI: 10.1016/j.vaccine.2014.06.057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
96 Oberle D, Pavel J, Mayer G, Geisler P, Keller-Stanislawski B; German Narcolepsy Study Group. Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. Sleep Med 2017;34:71-83. [PMID: 28522102 DOI: 10.1016/j.sleep.2017.02.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
97 Latorre D, Federica S, Bassetti CLA, Kallweit U. Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation. Semin Immunopathol 2022. [PMID: 35445831 DOI: 10.1007/s00281-022-00933-9] [Reference Citation Analysis]
98 Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Medicine 2015;16:9-18. [DOI: 10.1016/j.sleep.2014.10.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
99 Czako R, Subbarao K. Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virol 2015;10:1033-47. [PMID: 26587050 DOI: 10.2217/fvl.15.69] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
100 Izurieta P, Kim WJ, Wie SH, Lee J, Lee JS, Dramé M, Vaughn DW, Schuind A. Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study. Vaccine 2015;33:2800-7. [PMID: 25910919 DOI: 10.1016/j.vaccine.2015.04.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
101 Partinen M. Disconjugated binocular eye movements at onset of multiple sleep latency test in childhood narcolepsy: Disconjugated eye movements in MSLT. Sleep and Biological Rhythms 2013;11:6-8. [DOI: 10.1111/j.1479-8425.2012.00543.x] [Reference Citation Analysis]
102 Lind A, Freyhult E, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Lima Bomfim I, Fink K, Fex M, Törn C, Elding Larsson H, Lernmark Å. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Viral Immunol 2017;30:590-600. [PMID: 28796576 DOI: 10.1089/vim.2017.0066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
103 Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. J Clin Sleep Med 2017;13:441-53. [PMID: 28095967 DOI: 10.5664/jcsm.6500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
104 Li L, Honda-Okubo Y, Li C, Sajkov D, Petrovsky N. Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine. PLoS One 2015;10:e0132003. [PMID: 26177480 DOI: 10.1371/journal.pone.0132003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
105 Zhang Z, Gool JK, Fronczek R, Dauvilliers Y, Bassetti CLA, Mayer G, Plazzi G, Pizza F, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Del Rio-Villegas R, Heinzer R, Wierzbicka A, Young P, Högl B, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Lammers GJ, Khatami R. New 2013 incidence peak in childhood narcolepsy: more than vaccination? Sleep 2021;44:zsaa172. [PMID: 32909046 DOI: 10.1093/sleep/zsaa172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 van der Most R, Wettendorff M, Innis B, Hanon E. Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy". Sci Transl Med 2014;6:242le3. [PMID: 24964988 DOI: 10.1126/scitranslmed.3008906] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Brito LA, Malyala P, O'Hagan DT. Vaccine adjuvant formulations: a pharmaceutical perspective. Semin Immunol 2013;25:130-45. [PMID: 23850011 DOI: 10.1016/j.smim.2013.05.007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
108 Brillo E, Tosto V, Giardina I, Buonomo E. Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview. J Matern Fetal Neonatal Med 2021;34:3415-44. [PMID: 31645152 DOI: 10.1080/14767058.2019.1680633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
109 Nellore A, Randall TD. Narcolepsy and influenza vaccination-the inappropriate awakening of immunity. Ann Transl Med 2016;4:S29. [PMID: 27867997 DOI: 10.21037/atm.2016.10.60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
110 Johansen K. The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol 2014;56:1041-2. [DOI: 10.1111/dmcn.12543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
111 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
112 Gilbert SC. Influenza vaccines and immunopathology. Expert Review of Vaccines 2014;11:873-5. [DOI: 10.1586/erv.12.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
113 Scheer D, Schwartz SW, Parr M, Zgibor J, Sanchez-Anguiano A, Rajaram L. Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010. Sleep 2019;42:zsz091. [PMID: 31004158 DOI: 10.1093/sleep/zsz091] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
114 De la Herrán-Arita AK, García-García F. Narcolepsy as an immune-mediated disease. Sleep Disord 2014;2014:792687. [PMID: 24551456 DOI: 10.1155/2014/792687] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
115 Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Sleep 2017;40. [PMID: 28364477 DOI: 10.1093/sleep/zsw010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
116 Lernmark Å. Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy. Pediatr Diabetes 2016;17 Suppl 22:65-72. [PMID: 27411439 DOI: 10.1111/pedi.12390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
117 Ponziani V, Gennari M, Pizza F, Balsamo A, Bernardi F, Plazzi G. Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. J Clin Sleep Med 2016;12:1649-57. [PMID: 27707443 DOI: 10.5664/jcsm.6352] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
118 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
119 Johansen K, Brasseur D, Macdonald N, Nohynek H, Vandeputte J, Wood D, Neels P. Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines? Biologicals 2016;44:276-80. [DOI: 10.1016/j.biologicals.2016.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
120 Pizza F, Peltola H, Sarkanen T, Moghadam KK, Plazzi G, Partinen M. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. Sleep Medicine 2014;15:262-5. [DOI: 10.1016/j.sleep.2013.09.021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
121 Fraigne JJ, Grace KP, Horner RL, Peever J. Mechanisms of REM sleep in health and disease: . Current Opinion in Pulmonary Medicine 2014;20:527-32. [DOI: 10.1097/mcp.0000000000000103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Fox CB, Haensler J. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Rev Vaccines 2013;12:747-58. [PMID: 23885820 DOI: 10.1586/14760584.2013.811188] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
123 Chen YH, Huang YS, Chen CH. Increased plasma level of tumor necrosis factor α in patients with narcolepsy in Taiwan. Sleep Med 2013;14:1272-6. [PMID: 24157100 DOI: 10.1016/j.sleep.2013.04.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
124 Vignatelli L, Antelmi E, Ceretelli I, Bellini M, Carta C, Cortelli P, Ferini-Strambi L, Ferri R, Guerrini R, Ingravallo F, Marchiani V, Mari F, Pieroni G, Pizza F, Verga MC, Verrillo E, Taruscio D, Plazzi G. Red Flags for early referral of people with symptoms suggestive of narcolepsy: a report from a national multidisciplinary panel. Neurol Sci 2019;40:447-56. [PMID: 30539345 DOI: 10.1007/s10072-018-3666-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
125 Brodin P, Valentini D, Uhlin M, Mattsson J, Zumla A, Maeurer MJ. Systems level immune response analysis and personalized medicine. Expert Review of Clinical Immunology 2014;9:307-17. [DOI: 10.1586/eci.13.9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
126 Giannoccaro MP, Waters P, Pizza F, Liguori R, Plazzi G, Vincent A. Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy. Sleep 2017;40. [DOI: 10.1093/sleep/zsw056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
127 Han F, Lin L, Li J, Dong SX, An P, Zhao L, Liu NY, Li QY, Yan H, Gao ZC, Faraco J, Strohl KP, Liu X, Miyadera H, Mignot E. HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 2012;80:328-35. [PMID: 22862152 DOI: 10.1111/j.1399-0039.2012.01948.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
128 Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De Wals P. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014;9:e108489. [PMID: 25264897 DOI: 10.1371/journal.pone.0108489] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
129 Barateau L, Liblau R, Peyron C, Dauvilliers Y. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS Drugs 2017;31:821-34. [DOI: 10.1007/s40263-017-0464-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
130 Tsai JP, Baker AJ. Influenza-Associated Neurological Complications. Neurocrit Care 2013;18:118-30. [DOI: 10.1007/s12028-012-9796-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
131 Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, Julkunen I, Vuorela A, Vaarala O, Nohynek H, Pasini FL, Montomoli E, Trombetta C, Adams CM, Rothbard J, Steinman L. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015;7:294ra105. [PMID: 26136476 DOI: 10.1126/scitranslmed.aab2354] [Cited by in Crossref: 159] [Cited by in F6Publishing: 132] [Article Influence: 26.5] [Reference Citation Analysis]
132 Ahmed SS, Schur PH, Macdonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. Journal of Autoimmunity 2014;50:1-11. [DOI: 10.1016/j.jaut.2014.01.033] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 11.5] [Reference Citation Analysis]
133 Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012;345:e4445. [PMID: 22791791 DOI: 10.1136/bmj.e4445] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
134 Liu R, Jiang W, Mellins ED. Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA). Cell Mol Immunol 2021;18:1847-60. [PMID: 34117370 DOI: 10.1038/s41423-021-00717-5] [Reference Citation Analysis]
135 Del Giudice G, Fragapane E, Della Cioppa G, Rappuoli R. Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza. Expert Opin Biol Ther 2013;13:121-35. [PMID: 23189937 DOI: 10.1517/14712598.2013.748030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
136 Feketeova E, Tormasiova M, Klobučníková K, Durdik P, Jarcuskova D, Benca M, Vitkova M. Narcolepsy in Slovakia – Epidemiology, clinical and polysomnographic features, comorbid diagnoses: a case-control study. Sleep Medicine 2020;67:15-22. [DOI: 10.1016/j.sleep.2019.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Mohn KG, Zhou F. Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View. Vaccines (Basel) 2018;6:E32. [PMID: 29861454 DOI: 10.3390/vaccines6020032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
138 Lopalco PL, DeStefano F. The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines. Vaccine 2015;33:1541-8. [PMID: 25444788 DOI: 10.1016/j.vaccine.2014.10.047] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
139 Khatami R, Luca G, Baumann CR, Bassetti CL, Bruni O, Canellas F, Dauvilliers Y, Del Rio-villegas R, Feketeova E, Ferri R, Geisler P, Högl B, Jennum P, Kornum BR, Lecendreux M, Martins-da-silva A, Mathis J, Mayer G, Paiva T, Partinen M, Peraita-adrados R, Plazzi G, Santamaria J, Sonka K, Riha R, Tafti M, Wierzbicka A, Young P, Lammers GJ, Overeem S; European Narcolepsy Network. The European Narcolepsy Network (EU-NN) database. J Sleep Res 2016;25:356-64. [DOI: 10.1111/jsr.12374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
140 Grund S, Wichmann O, Mertens T, Hengel H. [Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:76-86. [PMID: 23275959 DOI: 10.1007/s00103-012-1590-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014;13:600-13. [PMID: 24849861 DOI: 10.1016/S1474-4422(14)70075-4] [Cited by in Crossref: 173] [Cited by in F6Publishing: 60] [Article Influence: 21.6] [Reference Citation Analysis]
142 Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, Castets S, Spiegel K, Lin JS, Arnulf I, Franco P. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013;19:521-8. [PMID: 23574649 DOI: 10.1111/cns.12105] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
143 Lind A, Akel O, Wallenius M, Ramelius A, Maziarz M, Zhao LP, Geraghty DE, Palm L, Lernmark Å, Larsson HE. HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy. PLoS One 2019;14:e0222882. [PMID: 31577807 DOI: 10.1371/journal.pone.0222882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
144 Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol 2015;6:123. [PMID: 26074874 DOI: 10.3389/fneur.2015.00123] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
145 Vaarala O, Vuorela A, Partinen M, Baumann M, Freitag TL, Meri S, Saavalainen P, Jauhiainen M, Soliymani R, Kirjavainen T, Olsen P, Saarenpää-Heikkilä O, Rouvinen J, Roivainen M, Nohynek H, Jokinen J, Julkunen I, Kilpi T. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. PLoS One 2014;9:e114361. [PMID: 25501681 DOI: 10.1371/journal.pone.0114361] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
146 Nevsimalova S. The Diagnosis and Treatment of Pediatric Narcolepsy. Curr Neurol Neurosci Rep 2014;14. [DOI: 10.1007/s11910-014-0469-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
147 Julkunen I, Partinen M. Neuroimmunology: Disease mechanisms in narcolepsy remain elusive. Nat Rev Neurol 2014;10:616-7. [PMID: 25311588 DOI: 10.1038/nrneurol.2014.191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
148 De la Herrán-Arita AK, Kornum BR, Mahlios J, Jiang W, Lin L, Hou T, Macaubas C, Einen M, Plazzi G, Crowe C, Newell EW, Davis MM, Mellins ED, Mignot E. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med 2013;5:216ra176. [PMID: 24353159 DOI: 10.1126/scitranslmed.3007762] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
149 Hauser MI, Muscatello DJ, Soh ACY, Dwyer DE, Turner RM. An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines. Vaccine 2019;37:4246-55. [PMID: 31253447 DOI: 10.1016/j.vaccine.2019.06.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
150 Trombetta CM, Gianchecchi E, Montomoli E. Influenza vaccines: Evaluation of the safety profile. Hum Vaccin Immunother 2018;14:657-70. [PMID: 29297746 DOI: 10.1080/21645515.2017.1423153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
151 Lind A, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Nilsson AL, Bomfim IL, Fink K, Lernmark Å. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. J Autoimmun 2014;50:99-106. [PMID: 24485154 DOI: 10.1016/j.jaut.2014.01.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
152 Treanor JJ, Szilagyi P. Editorial commentary: influenza vaccine: glass half full or half empty? Clin Infect Dis 2013;56:1370-2. [PMID: 23413421 DOI: 10.1093/cid/cit064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Kashiwagi S, Brauns T, Gelfand J, Poznansky MC. Laser vaccine adjuvants. History, progress, and potential. Hum Vaccin Immunother 2014;10:1892-907. [PMID: 25424797 DOI: 10.4161/hv.28840] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
154 Dietmann A, Horn MP, Schinkelshoek MS, Fronczek R, Salmen A, Bargiotas P, Lammers GJ, Khatami R, Bassetti CLA. Conventional autoantibodies against brain antigens are not routinely detectable in serum and CSF of narcolepsy type 1 and 2 patients. Sleep Med 2020;75:188-91. [PMID: 32858359 DOI: 10.1016/j.sleep.2020.08.001] [Reference Citation Analysis]
155 Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, Saarenpää-Heikkilä O, Kilpi T. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:e33536. [PMID: 22470453 DOI: 10.1371/journal.pone.0033536] [Cited by in Crossref: 351] [Cited by in F6Publishing: 295] [Article Influence: 35.1] [Reference Citation Analysis]
156 De la Herrán-arita AK, Equihua-benítez AC, Drucker-colín R. Treatment of cataplexy. Expert Opinion on Orphan Drugs 2013;1:199-210. [DOI: 10.1517/21678707.2013.765359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 2014;37:1601-8. [PMID: 25197808 DOI: 10.5665/sleep.4066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
158 Han F, Faraco J, Dong XS, Ollila HM, Lin L, Li J, An P, Wang S, Jiang KW, Gao ZC, Zhao L, Yan H, Liu YN, Li QH, Zhang XZ, Hu Y, Wang JY, Lu YH, Lu CJ, Zhou W, Hallmayer J, Huang YS, Strohl KP, Pollmächer T, Mignot E. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet 2013;9:e1003880. [PMID: 24204295 DOI: 10.1371/journal.pgen.1003880] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 10.8] [Reference Citation Analysis]
159 Wutzler P, Hardt R, Knuf M, Wahle K. Targeted vaccine selection in influenza vaccination. Dtsch Arztebl Int 2013;110:793-8. [PMID: 24314622 DOI: 10.3238/arztebl.2013.0793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
160 Mignot EJ. History of narcolepsy at Stanford University. Immunol Res 2014;58:315-39. [PMID: 24825774 DOI: 10.1007/s12026-014-8513-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
161 Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Scholz S, Crastes de Paulet B, Carlander B, Jaussent I. Vitamin D deficiency in type 1 narcolepsy: a reappraisal. Sleep Medicine 2017;29:1-6. [DOI: 10.1016/j.sleep.2016.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
162 Ravel JM, Mignot EJM. [Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T cell biology and molecular mimicry with flu epitopes]. Biol Aujourdhui 2019;213:87-108. [PMID: 31829930 DOI: 10.1051/jbio/2019026] [Reference Citation Analysis]
163 Lopez Bernal JA, Andrews N, Amirthalingam G. The Use of Quasi-experimental Designs for Vaccine Evaluation. Clinical Infectious Diseases 2019;68:1769-76. [DOI: 10.1093/cid/ciy906] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
164 Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
165 Oberle D, Pavel J, Keller-stanislawski B. Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany. Pharmacoepidemiol Drug Saf 2017;26:1321-7. [DOI: 10.1002/pds.4292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
166 Plazzi G, Pizza F. Childhood narcolepsy with cataplexy: a newly reported phenotype of an old disease? Sleep Med 2013;14:810-1. [PMID: 23831236 DOI: 10.1016/j.sleep.2013.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
167 Nguyen XH, Saoudi A, Liblau RS. Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation. Curr Opin Neurol 2016;29:362-71. [PMID: 27023738 DOI: 10.1097/WCO.0000000000000318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
168 Luo G, Yogeshwar S, Lin L, Mignot EJ. T cell reactivity to regulatory factor X4 in type 1 narcolepsy. Sci Rep 2021;11:7841. [PMID: 33837283 DOI: 10.1038/s41598-021-87481-8] [Reference Citation Analysis]
169 Thakur KT, Epstein S, Bilski A, Balbi A, Boehme AK, Brannagan TH, Wesley SF, Riley CS. Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present. Neurology 2021;97:767-75. [PMID: 34475124 DOI: 10.1212/WNL.0000000000012703] [Reference Citation Analysis]
170 Kobbe R. The ESPID/ESWI Joint Symposium - A strong vote for universal influenza vaccination in children in Europe. Vaccine 2015;33:6967-9. [PMID: 26386163 DOI: 10.1016/j.vaccine.2015.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
171 Thebault S, Vincent A, Gringras P. Narcolepsy and H1N1 vaccination: a link? Current Opinion in Pulmonary Medicine 2013;19:587-93. [DOI: 10.1097/mcp.0b013e328365af97] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
172 Bollaerts K, Shinde V, Dos Santos G, Ferreira G, Bauchau V, Cohet C, Verstraeten T. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy. PLoS One 2016;11:e0149289. [PMID: 26901063 DOI: 10.1371/journal.pone.0149289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
173 Moise L, Meyers LM, Jang H, Grizotte-Lake M, Boyle CM, McGonnigal B, Ge P, Ross TM, De Groot AS. Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice. Hum Vaccin Immunother 2022;:2082191. [PMID: 35704783 DOI: 10.1080/21645515.2022.2082191] [Reference Citation Analysis]
174 Peräsaari J, Saarela V, Nikkilä J, Ala-Houhala M, Arikoski P, Kataja J, Rönnholm K, Merenmies J, Nuutinen M, Jahnukainen T. HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish pediatric population: a nation-wide study. Tissue Antigens 2013;81:435-41. [PMID: 23594347 DOI: 10.1111/tan.12116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
175 Lividini A, Pizza F, Filardi M, Vandi S, Ingravallo F, Antelmi E, Bruni O, Cosentino FII, Ferri R, Guarnieri B, Marelli S, Ferini-Strambi L, Romigi A, Bonanni E, Maestri M, Terzaghi M, Manni R, Plazzi G. Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype. J Clin Sleep Med 2021;17:1363-70. [PMID: 33666167 DOI: 10.5664/jcsm.9198] [Reference Citation Analysis]
176 Silber MH. Autoimmune sleep disorders. Autoimmune Neurology. Elsevier; 2016. pp. 317-26. [DOI: 10.1016/b978-0-444-63432-0.00018-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
177 Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M, Rico TJ, Lichtner P, Dauvilliers Y, Arnulf I, Lecendreux M, Javidi S, Geisler P, Mayer G, Pizza F, Poli F, Plazzi G, Overeem S, Lammers GJ, Kemlink D, Sonka K, Nevsimalova S, Rouleau G, Desautels A, Montplaisir J, Frauscher B, Ehrmann L, Högl B, Jennum P, Bourgin P, Peraita-Adrados R, Iranzo A, Bassetti C, Chen WM, Concannon P, Thompson SD, Damotte V, Fontaine B, Breban M, Gieger C, Klopp N, Deloukas P, Wijmenga C, Hallmayer J, Onengut-Gumuscu S, Rich SS, Winkelmann J, Mignot E. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013;9:e1003270. [PMID: 23459209 DOI: 10.1371/journal.pgen.1003270] [Cited by in Crossref: 160] [Cited by in F6Publishing: 132] [Article Influence: 17.8] [Reference Citation Analysis]
178 Stowe J, Andrews N, Miller E. Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy. CNS Drugs 2020;34:1-8. [PMID: 31576507 DOI: 10.1007/s40263-019-00670-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
179 Edwards K, Hanquet G, Black S, Mignot E, Jankosky C, Shimabukuro T, Miller E, Nohynek H, Neels P. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting. Biologicals 2019;60:1-7. [PMID: 31130313 DOI: 10.1016/j.biologicals.2019.05.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
180 Elding Larsson H, Lynch KF, Lönnrot M, Haller MJ, Lernmark Å, Hagopian WA, She JX, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Rewers MJ, Hyöty H; TEDDY Study Group. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 2018;61:193-202. [PMID: 28990147 DOI: 10.1007/s00125-017-4448-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
181 Rowhani-Rahbar A, Klein NP, Baxter R. Assessing the safety of influenza vaccination in specific populations: children and the elderly. Expert Rev Vaccines 2012;11:973-84. [PMID: 23002978 DOI: 10.1586/erv.12.66] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
182 Siddiqui A, Adnan A, Abbas M, Taseen S, Ochani S, Essar MY. Revival of the heterologous prime‐boost technique in COVID ‐19: An outlook from the history of outbreaks. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.531] [Reference Citation Analysis]
183 Juvodden HT, Alnæs D, Lund MJ, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Hypocretin-deficient narcolepsy patients have abnormal brain activation during humor processing. Sleep 2019;42:zsz082. [DOI: 10.1093/sleep/zsz082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
184 Reading PJ. Update on narcolepsy. J Neurol 2019;266:1809-15. [DOI: 10.1007/s00415-019-09310-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
185 Sarkanen T, Alakuijala A, Partinen M. Clinical course of H1N1-vaccine-related narcolepsy. Sleep Medicine 2016;19:17-22. [DOI: 10.1016/j.sleep.2015.11.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
186 Lind A, Marzinotto I, Brigatti C, Ramelius A, Piemonti L, Lampasona V. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis. Sci Rep 2021;11:4063. [PMID: 33603024 DOI: 10.1038/s41598-021-83543-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
187 Poland GA, Whitaker JA, Poland CM, Ovsyannikova IG, Kennedy RB. Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol 2016;17:116-25. [PMID: 27039875 DOI: 10.1016/j.coviro.2016.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
188 Heier MS, Skinningsrud A, Paus E, Gautvik KM. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Sleep Med 2014;15:614-8. [PMID: 24784789 DOI: 10.1016/j.sleep.2014.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
189 Wu H, Zhuang J, Stone WS, Zhang L, Zhao Z, Wang Z, Yang Y, Li X, Zhao X, Zhao Z. Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in Eastern China. Sleep Medicine 2014;15:607-13. [DOI: 10.1016/j.sleep.2013.12.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
190 Nordstrand SH, Hansen BH, Kamaleri Y, Nilsen KB, Rootwelt T, Karlsen T, Knudsen S. Changes in quality of life in individuals with narcolepsy type 1 after the H1N1-influenza epidemic and vaccination campaign in Norway: a two-year prospective cohort study. Sleep Medicine 2018;50:175-80. [DOI: 10.1016/j.sleep.2018.05.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
191 Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. Vaccine 2018;36:6202-11. [PMID: 30122647 DOI: 10.1016/j.vaccine.2018.08.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
192 Zandian A, Forsström B, Häggmark-månberg A, Schwenk JM, Uhlén M, Nilsson P, Ayoglu B. Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy. J Proteome Res 2017;16:1300-14. [DOI: 10.1021/acs.jproteome.6b00916] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
193 Tozzi AE, Gesualdo F, D'Ambrosio A, Pandolfi E, Agricola E, Lopalco P. Can Digital Tools Be Used for Improving Immunization Programs? Front Public Health 2016;4:36. [PMID: 27014673 DOI: 10.3389/fpubh.2016.00036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
194 Pizza F, Franceschini C, Peltola H, Vandi S, Finotti E, Ingravallo F, Nobili L, Bruni O, Lin L, Edwards MJ, Partinen M, Dauvilliers Y, Mignot E, Bhatia KP, Plazzi G. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain 2013;136:3787-95. [PMID: 24142146 DOI: 10.1093/brain/awt277] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
195 August J, Maski K. Updates on Pediatric Sleep Disorders. Curr Sleep Medicine Rep 2020;6:163-75. [DOI: 10.1007/s40675-020-00184-w] [Reference Citation Analysis]
196 Miyagawa T, Toyoda H, Hirataka A, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Imai M, Fujimura Y, Tamura Y, Ikegami A, Wada Y, Moriya S, Furuya H, Kato M, Omata N, Kojima H, Kashiwase K, Saji H, Khor S, Yamasaki M, Wada Y, Ishigooka J, Kuroda K, Kume K, Chiba S, Yamada N, Okawa M, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K. New susceptibility variants to narcolepsy identified in HLA class II region. Human Molecular Genetics 2015;24:891-8. [DOI: 10.1093/hmg/ddu480] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
197 Whitaker JA, Ovsyannikova IG, Poland GA. Adversomics: a new paradigm for vaccine safety and design. Expert Rev Vaccines 2015;14:935-47. [PMID: 25937189 DOI: 10.1586/14760584.2015.1038249] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
198 Haidere MF, Ratan ZA, Nowroz S, Zaman SB, Jung YJ, Hosseinzadeh H, Cho JY. COVID-19 Vaccine: Critical Questions with Complicated Answers. Biomol Ther (Seoul) 2021;29:1-10. [PMID: 33372165 DOI: 10.4062/biomolther.2020.178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
199 Pillen S, Pizza F, Dhondt K, Scammell TE, Overeem S. Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol 2017;19:23. [PMID: 28478511 DOI: 10.1007/s11940-017-0459-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
200 Sunwoo J. Narcolepsy, autoimmunity, and influenza A H1N1 vaccination. encephalitis 2021;1:31-5. [DOI: 10.47936/encephalitis.2021.00010] [Reference Citation Analysis]
201 Maski K, Owens JA. Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management. Lancet Neurol 2016;15:1170-81. [PMID: 27647645 DOI: 10.1016/S1474-4422(16)30204-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
202 Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis 2014;1:ofu102. [PMID: 25734170 DOI: 10.1093/ofid/ofu102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
203 Soema PC, Kompier R, Amorij JP, Kersten GF. Current and next generation influenza vaccines: Formulation and production strategies. Eur J Pharm Biopharm 2015;94:251-63. [PMID: 26047796 DOI: 10.1016/j.ejpb.2015.05.023] [Cited by in Crossref: 174] [Cited by in F6Publishing: 145] [Article Influence: 24.9] [Reference Citation Analysis]
204 Del Giudice G, Rappuoli R. Inactivated and adjuvanted influenza vaccines. Curr Top Microbiol Immunol 2015;386:151-80. [PMID: 25038938 DOI: 10.1007/82_2014_406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
205 Shaw CA, Li D, Tomljenovic L. Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? Immunotherapy 2014;6:1055-71. [DOI: 10.2217/imt.14.81] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
206 Seong MJ, Hong SB. Autoimmunity and Immunotherapy in Narcolepsy. Sleep Med Res 2017;8:1-7. [DOI: 10.17241/smr.2017.00052] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
207 Sarkanen T, Niemelä V, Landtblom AM, Partinen M. Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate. Front Neurol 2014;5:136. [PMID: 25191304 DOI: 10.3389/fneur.2014.00136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
208 Häggmark-Månberg A, Zandian A, Forsström B, Khademi M, Lima Bomfim I, Hellström C, Arnheim-Dahlström L, Hallböök T, Darin N, Lundberg IE, Uhlén M, Partinen M, Schwenk JM, Olsson T, Nilsson P. Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity 2016;49:421-33. [PMID: 27206786 DOI: 10.1080/08916934.2016.1183655] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
209 Luo G, Lin L, Jacob L, Bonvalet M, Ambati A, Plazzi G, Pizza F, Leib R, Adams CM, Partinen M, Mignot EJ. Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases. PLoS One 2017;12:e0187305. [PMID: 29220370 DOI: 10.1371/journal.pone.0187305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
210 Sarkanen T, Alakuijala A, Julkunen I, Partinen M. Narcolepsy Associated with Pandemrix Vaccine. Curr Neurol Neurosci Rep 2018;18:43. [PMID: 29855798 DOI: 10.1007/s11910-018-0851-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
211 Lecendreux M, Libri V, Jaussent I, Mottez E, Lopez R, Lavault S, Regnault A, Arnulf I, Dauvilliers Y. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ? J Autoimmun 2015;60:20-31. [PMID: 25892508 DOI: 10.1016/j.jaut.2015.03.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
212 Nordstrand SEH, Hansen BH, Rootwelt T, Karlsen T, Swanson D, Nilsen KB, Knudsen S. Psychiatric symptoms in patients with post-H1N1 narcolepsy type 1 in Norway. Sleep 2019;42. [DOI: 10.1093/sleep/zsz008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
213 Zhou F, Trieu M, Davies R, Cox RJ. Improving influenza vaccines: challenges to effective implementation. Current Opinion in Immunology 2018;53:88-95. [DOI: 10.1016/j.coi.2018.04.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
214 Sakala IG, Honda-Okubo Y, Fung J, Petrovsky N. Influenza immunization during pregnancy: Benefits for mother and infant. Hum Vaccin Immunother 2016;12:3065-71. [PMID: 27494630 DOI: 10.1080/21645515.2016.1215392] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
215 Degn M, Kornum BR. Type 1 narcolepsy: a CD8(+) T cell-mediated disease? Ann N Y Acad Sci 2015;1351:80-8. [PMID: 26096261 DOI: 10.1111/nyas.12793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
216 Com G, Einen MA, Jambhekar S. Narcolepsy with cataplexy: diagnostic challenge in children. Clin Pediatr (Phila) 2015;54:5-14. [PMID: 24623174 DOI: 10.1177/0009922814526301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Landtblom AM, Engström M. The sleepy teenager - diagnostic challenges. Front Neurol 2014;5:140. [PMID: 25136329 DOI: 10.3389/fneur.2014.00140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
218 Giannoccaro MP, Liguori R, Plazzi G, Pizza F. Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nat Sci Sleep 2021;13:557-77. [PMID: 34007229 DOI: 10.2147/NSS.S275931] [Reference Citation Analysis]
219 Lacroix C, Mallaret M, Jonville-bera A. Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance Centres. Therapies 2020;75:207-13. [DOI: 10.1016/j.therap.2020.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Baumann CR, Mignot E, Lammers GJ, Overeem S, Arnulf I, Rye D, Dauvilliers Y, Honda M, Owens JA, Plazzi G, Scammell TE. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep 2014;37:1035-42. [PMID: 24882898 DOI: 10.5665/sleep.3756] [Cited by in Crossref: 92] [Cited by in F6Publishing: 72] [Article Influence: 11.5] [Reference Citation Analysis]
221 Engström M, Hallböök T, Szakacs A, Karlsson T, Landtblom AM. Functional magnetic resonance imaging in narcolepsy and the kleine-levin syndrome. Front Neurol 2014;5:105. [PMID: 25009530 DOI: 10.3389/fneur.2014.00105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
222 Hovi M, Heiskala H, Aronen ET, Saarenpää-Heikkilä O, Olsen P, Nokelainen P, Kirjavainen T. Finnish children who experienced narcolepsy after receiving the Pandemrix vaccine during the 2009-2010 H1N1 pandemic demonstrated high level of psychosocial problems. Acta Paediatr 2022;111:850-8. [PMID: 34932852 DOI: 10.1111/apa.16233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Ambati A, Poiret T, Svahn B, Valentini D, Khademi M, Kockum I, Lima I, Arnheim-dahlström L, Lamb F, Fink K, Meng Q, Kumar A, Rane L, Olsson T, Maeurer M. Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases. J Intern Med 2015;278:264-76. [DOI: 10.1111/joim.12355] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
224 Alakuijala A, Sarkanen T, Partinen M. Polysomnographic and actigraphic characteristics of patients with H1N1-vaccine-related and sporadic narcolepsy. Sleep Med 2015;16:39-44. [PMID: 25554349 DOI: 10.1016/j.sleep.2014.07.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
225 Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386-95. [DOI: 10.1038/nrneurol.2014.97] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
226 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
227 Vesikari T, Richardus JH, Berglund J, Korhonen T, Flodmark C, Lindstrand A, Silfverdal SA, Bambure V, Caplanusi A, Dieussaert I, Roy-ghanta S, Vaughn DW. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. Pediatric Infectious Disease Journal 2015;34:774-82. [DOI: 10.1097/inf.0000000000000709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
228 Han F. Narcolepsy in China: when the east meets the west. Sleep Medicine 2014;15:605-6. [DOI: 10.1016/j.sleep.2014.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
229 Gu Y, Shimada T, Yasui Y, Tada Y, Kaku M, Okabe N. National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic. PLoS One 2013;8:e54786. [PMID: 23355899 DOI: 10.1371/journal.pone.0054786] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
230 Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, Pollard AJ, van Crevel R, Wilson CB. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol 2016;16:392-400. [PMID: 27157064 DOI: 10.1038/nri.2016.43] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 21.2] [Reference Citation Analysis]
231 Viste R, Lie BA, Viken MK, Rootwelt T, Knudsen-Heier S, Kornum BR. Narcolepsy type 1 patients have lower levels of effector memory CD4+ T cells compared to their siblings when controlling for H1N1-(Pandemrix™)-vaccination and HLA DQB1∗06:02 status. Sleep Med 2021;85:271-9. [PMID: 34388506 DOI: 10.1016/j.sleep.2021.07.024] [Reference Citation Analysis]
232 Honda-Okubo Y, Saade F, Petrovsky N. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine 2012;30:5373-81. [PMID: 22728225 DOI: 10.1016/j.vaccine.2012.06.021] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 10.6] [Reference Citation Analysis]
233 Gauci S, Hosking W, Bruck D, Schumacher U. Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine 2017;4:1312791. [DOI: 10.1080/2331205x.2017.1312791] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
234 Lehmann BA, Ruiter RA, Kok G. A qualitative study of the coverage of influenza vaccination on Dutch news sites and social media websites. BMC Public Health 2013;13:547. [PMID: 23738769 DOI: 10.1186/1471-2458-13-547] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
235 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 855-872.e7. [DOI: 10.1016/b978-0-323-24288-2.00089-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
236 Bomfim IL, Lamb F, Fink K, Szakács A, Silveira A, Franzén L, Azhary V, Maeurer M, Feltelius N, Darin N, Hallböök T, Arnheim-Dahlström L, Kockum I, Olsson T. The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction. Genes Immun 2017;18:75-81. [PMID: 28332559 DOI: 10.1038/gene.2017.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
237 Ludwig B, Smith S, Heussler H. Associations Between Neuropsychological, Neurobehavioral and Emotional Functioning and Either Narcolepsy or Idiopathic Hypersomnia in Children and Adolescents. J Clin Sleep Med 2018;14:661-74. [PMID: 29609710 DOI: 10.5664/jcsm.7066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
238 Kornum BR. Narcolepsy Type I as an autoimmune disorder. Handb Clin Neurol 2021;181:161-72. [PMID: 34238455 DOI: 10.1016/B978-0-12-820683-6.00012-9] [Reference Citation Analysis]
239 Dixon GN, Mckeever BW, Holton AE, Clarke C, Eosco G. The Power of a Picture: Overcoming Scientific Misinformation by Communicating Weight-of-Evidence Information with Visual Exemplars: The Power of a Picture. J Commun 2015;65:639-59. [DOI: 10.1111/jcom.12159] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
240 Moresco M, Lecciso M, Ocadlikova D, Filardi M, Melzi S, Kornum BR, Antelmi E, Pizza F, Mignot E, Curti A, Plazzi G. Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease. Sleep Medicine 2018;44:53-60. [DOI: 10.1016/j.sleep.2017.11.1150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
241 Hansen BH, Juvodden HT, Nordstrand SH, Viste R, Thorsby PM, Swanson D, Nilsen KB, Nærland T, Knudsen-heier S. High prevalence of ADHD symptoms in unmedicated youths with post-H1N1 narcolepsy type 1. Sleep Medicine 2020;75:171-80. [DOI: 10.1016/j.sleep.2020.06.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
242 Hu Z, Jiao X, Liu X. Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design. Front Microbiol 2017;8:1898. [PMID: 29018438 DOI: 10.3389/fmicb.2017.01898] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
243 Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-heier S. HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 2020;43:zsz239. [DOI: 10.1093/sleep/zsz239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
244 Petrovsky N. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs. Drug Saf 2015;38:1059-74. [PMID: 26446142 DOI: 10.1007/s40264-015-0350-4] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 21.3] [Reference Citation Analysis]
245 Mayer G. [Narcolepsy]. Nervenarzt 2014;85:26, 28-34. [PMID: 24408296 DOI: 10.1007/s00115-013-3889-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
246 Skwarczynski M, Toth I. Peptide-based synthetic vaccines. Chem Sci 2016;7:842-54. [PMID: 28791117 DOI: 10.1039/c5sc03892h] [Cited by in Crossref: 244] [Cited by in F6Publishing: 119] [Article Influence: 34.9] [Reference Citation Analysis]
247 Honda-Okubo Y, Ong CH, Petrovsky N. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection. Vaccine 2015;33:4892-900. [PMID: 26232344 DOI: 10.1016/j.vaccine.2015.07.051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
248 Lee RU, Radin JM. A population-based epidemiologic study of adult-onset narcolepsy incidence and associated risk factors, 2004-2013. J Neurol Sci 2016;370:29-34. [PMID: 27772778 DOI: 10.1016/j.jns.2016.08.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
249 Melén K, Partinen M, Tynell J, Sillanpää M, Himanen SL, Saarenpää-Heikkilä O, Hublin C, Olsen P, Ilonen J, Nohynek H, Syrjänen R, Kilpi T, Vuorela A, Kirjavainen T, Vaarala O, Julkunen I. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. PLoS One 2013;8:e68402. [PMID: 23950869 DOI: 10.1371/journal.pone.0068402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
250 Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine 2013;31 Suppl 1:A1-20. [PMID: 23587330 DOI: 10.1016/j.vaccine.2013.02.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
251 Janssens KAM, Quaedackers L, Lammers GJ, Amesz P, van Mierlo P, Aarts L, Peeters E, Hendriks D, Vandenbussche N, Overeem S, Pillen S. Effect of treatment on cognitive and attention problems in children with narcolepsy type 1. Sleep 2020;43:zsaa114. [PMID: 32505131 DOI: 10.1093/sleep/zsaa114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Vuorela A, Freitag TL, Leskinen K, Pessa H, Härkönen T, Stracenski I, Kirjavainen T, Olsen P, Saarenpää-Heikkilä O, Ilonen J, Knip M, Vaheri A, Partinen M, Saavalainen P, Meri S, Vaarala O. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1. Nat Commun 2021;12:2283. [PMID: 33863907 DOI: 10.1038/s41467-021-22637-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
253 Heier M, Gautvik K, Wannag E, Bronder K, Midtlyng E, Kamaleri Y, Storsaeter J. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Medicine 2013;14:867-71. [DOI: 10.1016/j.sleep.2013.03.020] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
254 Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med 2013;19:1597-608. [PMID: 24309663 DOI: 10.1038/nm.3409] [Cited by in Crossref: 675] [Cited by in F6Publishing: 641] [Article Influence: 75.0] [Reference Citation Analysis]